Are testosterone ranges of 300-1200 ng/dL really 'natural'?

What did @lizokryptonianreborn0 actually say?

The creator made several distinct claims packed into a short video. First, that a prolonged calorie deficit combined with aggressive cardio and dehydration, not low body fat itself, is what crashes testosterone. Second, that 1,000 ng/dL is not "too high to be natural." Third, and most importantly for this fact-check, that most of their TRT clients run testosterone levels "between 5,500 and 2,500 nanogram per deciliter." They used this to argue that TRT patients aren't simply replacing lost testosterone but are, in their words, "pretty much on gear."

The creator also showed what they claimed were lab results from a TRT client as evidence. The framing throughout was that TRT, as commonly practiced, blows past physiological ranges, making it functionally equivalent to anabolic steroid use. That's a bold claim, and it deserves a serious look.

Does the science back this up?

On the calorie deficit point, they're largely correct. On the TRT dosing range they described, the numbers are plausible for aggressive or poorly supervised protocols, but they're not representative of standard medical TRT. On the natural ceiling of 1,000 ng/dL, they're on solid ground.

The normal reference range for total testosterone in adult men is approximately 300–1,000 ng/dL, though some labs extend this to 1,100 ng/dL. Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism) established these ranges using large population samples. Values near 1,000 ng/dL are uncommon but documented in healthy young men, particularly athletes. The idea that hitting 1,000 ng/dL proves someone is on drugs is not supported by the literature.

On deficits and testosterone: Röjdmark et al. (1989, Metabolism) and more recently Smith et al. (2021, Frontiers in Endocrinology) both confirm that severe caloric restriction suppresses gonadotropins and reduces testosterone. Low body fat alone is not the primary driver. The creator got this right.

On TRT levels of 2,500–5,500 ng/dL: that's not therapeutic dosing by any clinical standard. Guideline-based TRT targets mid-normal range, roughly 400–700 ng/dL. Levels above 1,500 ng/dL are considered supratherapeutic by the Endocrine Society's 2018 clinical practice guidelines.

What did they get wrong (or right)?

They got the calorie deficit claim right, and the 1,000 ng/dL natural ceiling point is defensible. Where they went wrong is presenting a client running 2,500–5,500 ng/dL as representative of TRT, when it isn't.

Levels in the 2,500–5,500 ng/dL range are not TRT. They are supraphysiological by a significant margin and would be considered misuse or abuse of testosterone in any clinical context. Presenting these numbers as "what most TRT clients" experience misleads viewers who may be considering legitimate hormone therapy for documented hypogonadism. Standard monitored TRT, when prescribed and titrated appropriately, does not routinely produce levels above 1,500 ng/dL. The Endocrine Society, the American Urological Association, and the American Association of Clinical Endocrinology all set target ranges well below what this creator described.

To their credit, they acknowledged that TRT dosing depends on "the prescribed dose and individual androgen receptor responsiveness." But this caveat got buried under the stronger claim that TRT is basically gear. That framing is going to stick with 10,800 viewers far longer than the nuance did.

What should you actually know?

If you're researching TRT, the numbers in this video should not be your reference point. Here's what actually matters.

Hypogonadism is diagnosed when total testosterone falls below 300 ng/dL on two morning measurements, per Endocrine Society criteria. The goal of medically supervised TRT is to bring levels into mid-normal physiological range, not to push past 1,000 ng/dL. If a prescriber is targeting 2,500 ng/dL or higher, that falls outside standard of care and carries real cardiovascular, hematological, and hormonal risks.

The creator's broader argument, that many people using TRT are effectively using anabolic steroids, has merit when applied to poorly supervised or self-directed use. But conflating that with all TRT is misleading to people who have actual clinical indications for hormone therapy.

• Natural testosterone peaks in the late teens to early twenties and declines roughly 1–2% per year after 30 (Harman et al., 2001, Journal of Clinical Endocrinology and Metabolism).
• Caloric deficit magnitude and duration both matter for testosterone suppression, not just body fat percentage.
• Supratherapeutic testosterone levels increase erythrocytosis risk, cardiovascular strain, and suppress endogenous production long-term.